The Intracranial Pressure Monitoring Devices Market is bound to grow at a remarkable rate in the forecast period. Vital Sign monitoring, in combination with wearables, does aid in symptoms check-in as well as education 24/7. There are also hand-held dongles being made available for attaching to smartphones to measure biomarkers for chronic ailments. This monitoring proves to be more cost-effective and convenient in comparison with in-person care. This trend would be prevalent in the healthcare vertical going forward.
In a recent study done by Persistence Market Research, the global intracranial pressure (ICP) monitoring market recorded a market value of US$ 210.4 Mn in 2020. The market is further expected to expand at a CAGR of 4.9% over the forecast period of 2021-2031.
Intracranial pressure monitoring devices are used for the monitoring of increased level of intracranial pressure or the pressure of cerebrospinal fluid. Such devices are widely used in case of certain diseases such as subarachnoid hemorrhage, hydrocephalus, and malignant cerebral infarction (MCI) for providing proper treatment based on the testing.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/5450
There has been various technological advancements in recent times such as development of wireless ICP monitoring devices. Furthermore, innovation and approval for home-based ICP monitoring devices for patients suffering from hydrocephalus has been rising.
- For instance, the Raumed Home ICP device manufactured by Raumedic in 2019, also adds to the convenience of use of these products from the comfort of homes. The device allows the storing of certain activities on the handheld device, such as eating, sleeping, nausea, etc., with just the touch of a button. This provides better insights for therapy by neurosurgeons, which results in better treatment.
Company Profiles:
- Integra Lifesciences Corporation
- Medtronic Plc.
- Johnson & Johnson (DePuy Synthes)
- Sophysa Ltd
- Spiegelberg GmbH & Co
- Natus Medical Incorporated
- RAUMEDIC, Inc
- Gaeltec Devices Ltd
- IRRAS AB
- Nisonic
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/5450
Key Takeaways from Market Study
- Intracranial pressure monitoring devices used for measuring elevated intracranial pressure in the brain held more than 85% market share in 2020.
- Intraventricular route of intervention held approximately 50% of the global market share in 2020.
- Traumatic brain injury (TBI) is the most commonly seen indication for which ICP monitoring devices are used. TBI held a market share of around 37% in 2020.
- Hospitals are preferred more by patients as they use a variety of techniques to monitor ICP- clinical examination, do brain imaging, and use ICP monitors, with overall easy reimbursement procedures. Hospitals accounted for nearly one-fourth of the global market share in 2020.
- In 2020, North America dominated the ICP monitoring devices market, accounting for more than 55% of global market share.
“Increased cases of neurological diseases and advancements in diagnostics will propel demand for ICP monitoring devices over the coming years,” says an analyst of Persistence Market Research.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/5450
Market Competition
Key manufacturers of ICP)monitoring devices are focusing on strategic partnerships with institutes and hospitals for the marketing of their products, getting approvals from various regulatory authorities globally, and expanding their portfolios for gaining market position.
- In October 2021, IRRAS collaborated with Aarhus University Hospital in Aarhus, Denmark, one of the world’s leading medical institutions. This collaboration helped in the business of IRRAflow.
- Again, in December 2021, the company collaborated with the Lovell Government Services to sell IRRAflow and Hummingbird ICP product lines to Veterans Affairs (VA) hospitals and other U.S. government and military medical facilities.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the intracranial pressure (ICP) monitoring market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.
The research study is based on product (ICP monitoring products and accessories), route of intervention (intraventricular, subdural, epidural, parenchymal, and subarachnoid), indication (traumatic brain injury, intracerebral haemorrhage, subarachnoid haemorrhage, hydrocephalus, malignant cerebral infarction (MCI), cerebral edema, CNS infections, and others), and end user (hospitals, ambulatory surgical centers, trauma centers, and neurosurgery centers), across seven key regions of the world.
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
US Office: 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Japan Office: 1-2-1 Kinshi Arca Central Building
14/F Tokyo, 130-0013, Japan
Call – 1-888-863-3700
Sales – [email protected]
The Global Intracranial Pressure Monitoring Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.DriversRising cases of neurological disordersIncreasing incidence of traumatic brain injuriesRestraintsDearth of trained workforceHigh cost of deviceThe comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.
The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.The report classifies the market into different segments based on technique and application.
These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.
The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Browse the complete Global Intracranial Pressure Monitoring Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/20905-intracranial-pressure-icp-monitoring-devices-market-reportThe report also covers the complete competitive landscape of the global Intracranial Pressure Monitoring Devices market with company profiles of key players such as:Codman & Shurtleff Inc.Integra LifeSciences Holdings CorporationMedtronic plcOrsan Medical TechnologiesRAUMEDIC AGSophysa Ltd.Spiegelberg GmbH & Co. KGVittamedA detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.SEGMENTATIONS IN THE REPORT:By Technique:InvasiveExternal Ventricular DrainageMicrotransducer Icp MonitoringNon-InvasiveTranscranial Doppler UltrasonographyTympanic Membrane DisplacementOptic Nerve Sheath DiameterMri/CtFundoscopyBy Applications:Traumatic Brain InjuryIntracerebral HemorrhageMeningitisSubarachnoid HemorrhageOthersBy Geography:North America (NA) – US, Canada & Rest of North AmericaEurope (EU) – UK, Germany, France & Rest of EuropeAsia Pacific (APAC) – China, Japan, India & Rest of APACLatin America (LA) – Brazil & Rest of Latin AmericaMiddle East & Africa (MEA) – Middle East and AfricaDownload Free Sample Report of Global Intracranial Pressure Monitoring Devices Market @ https://www.decisiondatabases.com/contact/download-sample-20905The Global Intracranial Pressure Monitoring Devices Market has been exhibited in detail in the following chapters -Chapter 1 Intracranial Pressure Monitoring Devices Market PrefaceChapter 2 Executive SummaryChapter 3 Intracranial Pressure Monitoring Devices Industry AnalysisChapter 4 Intracranial Pressure Monitoring Devices Market Value Chain AnalysisChapter 5 Intracranial Pressure Monitoring Devices Market Analysis By TechniqueChapter 6 Intracranial Pressure Monitoring Devices Market Analysis By ApplicationsChapter 7 Intracranial Pressure Monitoring Devices Market Analysis By GeographyChapter 8 Competitive Landscape Of Intracranial Pressure Monitoring Devices CompaniesChapter 9 Company Profiles Of Intracranial Pressure Monitoring Devices IndustryPurchase the complete Global Intracranial Pressure Monitoring Devices Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-20905Other Reports by DecisionDatabases.com:Global Anesthesia Monitoring Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Cardiac Arrhythmia Monitoring Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends And ForecastAbout-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
Global Intra-cranial pressure (ICP) Monitor Market information, by techniques (invasive and non-invasive), by methods (intra-ventricular catheter, subdural screw, epidural sensor) by application (traumatic brain injury, intra-cerebral hemorrhage, meningitis and others), Forecast till 2027Market SynopsisMarket Research Future (MRFR) postulates that the global intracranial pressure (ICP) monitoring market is likely to exhibit 7.1% CAGR during the forecast period (2018-2024) due to the increasing prevalence of neurovascular diseases like brain aneurysm and arteriovenous malformations.
Intracranial pressure monitoring devices are especially designed to measure the pressure within the cranium which is caused by accident and trauma.
Such devices are generally used to treat traumatic brain injury.
The device helps to sense the pressure caused inside the skull and transports the measurements to a recording device.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/2042 Market Potential and PitfallsWith the increasing incidences of neurovascular diseases like brain aneurysm and arteriovenous malformations, the global intracranial pressure (ICP) monitoring market is predicted to foster during the forecast period.
Moreover, the surging biotechnology sector is likely to cause a shift in the sector and result in the growth of ICP monitoring market.With the emergence of advanced ICP monitoring devices, the limitations of earlier devices like leveling and de-bubbling of fluid-filled systems and shift in baseline pressure have been eliminated.
Moreover, the upswing in cases of brain surgeries in adults as well as children has triggered the demand for ICP monitors.On the contrary, high procedural costs of such devices coupled with the dearth of skilled personnel are some of the concerns anticipated to deter the market growth in the coming years.Global Intracranial Pressure (ICP) Monitoring Market: Segmental AnalysisThe global intracranial pressure (ICP) monitoring market has been segmented on the basis of technique, route of intervention, application, device, and end-user.By mode of route of intervention, the global intracranial pressure (ICP) monitoring market has been segmented into epidural and intraventricular sensor.By mode of technique, the global intracranial pressure (ICP) monitoring market has been segmented into non-invasive and invasive.By mode of devices, the global intracranial pressure (ICP) monitoring market has been segmented into subarachnoid screw, intraventricular catheter, non-invasive ICP monitors, and epidural sensors.By mode of applications, the global intracranial pressure (ICP) monitoring market has been segmented into intracerebral hemorrhage, traumatic brain injury, meningitis, and subarachnoid hemorrhage.
Autologous Stem Cell and Non-Stem Cell Based Therapies Market individual's own undivided cells or stem cells are collected and transplanted back to the person after intensive therapy.
These therapies are performed using hematopoietic stem cells, in some cases, cardiac cells are used to correct the damage caused by heart attacks.
Autologous and non-systemic stem cell therapies are used to treat different diseases, for example neurodegenerative diseases, cardiovascular diseases, cancer and autoimmune diseases, parasitic diseases.Europe autologous stem cell and non-stem cell based therapies market is registering a substantial CAGR in the forecast period of 2019-2026.
The report contains data from the base year of 2018 and the historic year of 2017.
The rise in the market can be attributed growing awareness of the therapeutic potential of stem cells in effective disease management and increased public-private investment in the development of stem cell therapies.
Get Sample Report at : https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-autologous-stem-cell-and-non-stem-cell-based-therapies-marketCompetitive Analysis: Europe Autologous Stem Cell and Non-Stem Cell Based Therapies MarketFew of the major market competitors currently working in the Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market are Takeda Pharmaceutical Company Limited, Cytori Therapeutics Inc., General Electric Spiegelberg GmbH & Co. KG ., Medtronic, Natus Medical Incorporated., Integra LifeSciences Corporation, RAUMEDIC AG, Abbott., Endotronix, Inc. among others.Key Pointers Covered in the Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Trends and Forecast to 2026Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market New Sales VolumesEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Replacement Sales VolumesEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Installed BaseEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market By BrandsEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market SizeEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Procedure VolumesEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Product Price AnalysisEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Healthcare OutcomesEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Cost of Care AnalysisEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Regulatory Framework and ChangesEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Prices and Reimbursement AnalysisEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Shares in Different RegionsRecent Developments for Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market CompetitorsEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Upcoming ApplicationsEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Innovators StudyGet Detailed TOC:https://www.databridgemarketresearch.com/toc/?dbmr=europe-autologous-stem-cell-and-non-stem-cell-based-therapies-marketScope of the Autologous Stem Cell and Non-Stem Cell Based Therapies MarketEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market By Applications (Eurodegenerative Disorders, Autoimmune Diseases, Cancer & Tumors, Cardiovascular Diseases), By Product (Blood Pressure (BP) Monitoring Devices, Pulmonary Pressure Monitoring Devices, Intracranial Pressure (ICP) Monitoring Devices), By End User (Hospitals and Ambulatory Surgical Center), Country (Germany , France , United Kingdom , Italy, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe) - Industry Trends and Forecast to 2026Europe autologous stem cell and non-stem cell based therapies market is registering a substantial CAGR in the forecast period of 2019-2026.
Autologous Stem Cell and Non-Stem Cell Based Therapies Market individual's own undivided cells or stem cells are collected and transplanted back to the person after intensive therapy.
These therapies are performed using hematopoietic stem cells, in some cases, cardiac cells are used to correct the damage caused by heart attacks.
Autologous and non-systemic stem cell therapies are used to treat different diseases, for example neurodegenerative diseases, cardiovascular diseases, cancer and autoimmune diseases, parasitic diseases.Europe autologous stem cell and non-stem cell based therapies market is registering a substantial CAGR in the forecast period of 2019-2026.
The report contains data from the base year of 2018 and the historic year of 2017.
The rise in the market can be attributed growing awareness of the therapeutic potential of stem cells in effective disease management and increased public-private investment in the development of stem cell therapies.
Get Sample Report at : https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-autologous-stem-cell-and-non-stem-cell-based-therapies-marketCompetitive Analysis: Europe Autologous Stem Cell and Non-Stem Cell Based Therapies MarketFew of the major market competitors currently working in the europe autologous stem cell and non-stem cell based therapies market are Takeda Pharmaceutical Company Limited, Cytori Therapeutics Inc., General Electric Spiegelberg GmbH & Co. KG ., Medtronic, Natus Medical Incorporated., Integra LifeSciences Corporation, RAUMEDIC AG, Abbott., Endotronix, Inc. among others.Key Pointers Covered in the Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Trends and Forecast to 2026Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market New Sales VolumesEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Replacement Sales VolumesEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Installed BaseEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market By BrandsEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market SizeEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Procedure VolumesEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Product Price AnalysisEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Healthcare OutcomesEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Cost of Care AnalysisEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Regulatory Framework and ChangesEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Prices and Reimbursement AnalysisEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Shares in Different RegionsRecent Developments for Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market CompetitorsEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Upcoming ApplicationsEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market Innovators StudyGet Detailed TOC:https://www.databridgemarketresearch.com/toc/?dbmr=europe-autologous-stem-cell-and-non-stem-cell-based-therapies-marketScope of the Autologous Stem Cell and Non-Stem Cell Based Therapies MarketEurope Autologous Stem Cell and Non-Stem Cell Based Therapies Market By Applications (Eurodegenerative Disorders, Autoimmune Diseases, Cancer & Tumors, Cardiovascular Diseases), By Product (Blood Pressure (BP) Monitoring Devices, Pulmonary Pressure Monitoring Devices, Intracranial Pressure (ICP) Monitoring Devices), By End User (Hospitals and Ambulatory Surgical Center), Country (Germany , France , United Kingdom , Italy, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe) - Industry Trends and Forecast to 2026Europe autologous stem cell and non-stem cell based therapies market is registering a substantial CAGR in the forecast period of 2019-2026.
